MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Dec 7, 2025Expired
- Award
- Agreement
- Framework agreementuntil May 2026
Brief
MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE
Farmasøytisk engroshandel
Result
- VIFOR FRANCEWinner
- 3Number of tenders received
- Not statedContract value
- Maximum framework agreement valueUp to €1,272,224
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Centre Hospitalier de Valenciennes
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Prix et technique
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE
Contact
Cellule des marchés publicsdhont-n@ch-valenciennes.fr- Result · Framework agreementType
- NordLocation
- 33690000Main codeVarious medicinal products